Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03413449 · ClinicalTrials.gov registry record
A Prospective Study Frailty for Esophagectomy and Lung Resection in Thoracic Surgery
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 360
- Enrollment target
NCT03413449: Completed study, sponsored by The Cleveland Clinic.
NCT03413449 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 360 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03413449 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 360 participants
- Enrollment target
Study Summary
The purpose of this study is to develop an all-encompassing frailty model using laboratory and functional studies. A frailty model will help us determine prior to surgery who will require rehabilitation and skilled nursing needs beyond discharge. This model will also help us determine who will likely be readmitted and why they will be readmitted. Understanding these things can help us prevent some of them from occurring in the future.
Primary Outcome
Number of STS defined complications (chest tube airleak, atelectasis, pleural effusion requiring drain, pneumonia, ARDS, respiratory failure, bronchopleural fistula, PE, pneumothorax, chylothorax, ventilator \> 48 hours, tracheostomy, tracheobronchial injury, ileus, anastomotic leak, GI dilation, conduit necrosis requiring surgery, delayed conduit emptying, C. diff, delirium) will be combined to report the number of morbidity events
Interventions
- DIAGNOSTIC_TEST Frailty model
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 360 participants |
| Start Date | 2018-01-08 |
| Est. Completion | 2024-11-08 |
What the finished NCT03413449 record still lists
NCT03413449 is an observational study that tracks outcomes without assigning an intervention. The registered 360 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Frailty model is the first listed.
NCT03413449 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03413449 about?
NCT03413449 is a clinical study titled "A Prospective Study Frailty for Esophagectomy and Lung Resection in Thoracic Surgery". The purpose of this study is to develop an all-encompassing frailty model using laboratory and functional studies. A frailty model will help us determine prior to surgery who will require rehabilitation and skilled nursing needs beyond discharge. This model will also help us determine who will likel...
What is the current status of trial NCT03413449?
This trial is currently completed. The enrollment target is 360 participants. The study started on 2018-01-08. Estimated completion is 2024-11-08.
What interventions are being tested in trial NCT03413449?
The interventions under investigation include: Frailty model (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03413449?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747836 · 360 participants
Ultrasound Analysis of Human Carpal Tunnel System
- NCT04089046 · 360 participants · NA
Telemedicine Enhanced Asthma Management - Uniting Providers for Teens (TEAM-UP for Teens)
- NCT04130503 · 360 participants · NA
The Recovery in Stroke Using PAP Study
- NCT04160000 · 360 participants · Phase 4
Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI